The amino terminus of Cdk2 binds p21

N K Moskowitz1, F J Borao, O Dardashti

  • 1University of Medicine and Dentistry of New Jersey, Cancer Institute of New Jersey, New Brunswick 08901, USA.

Oncology Research
|January 1, 1996
PubMed

Insights

The cyclin-dependent kinase (Cdk) inhibitor p21 binds to Cdk2, with the amino-terminal half of Cdk2 being crucial for this interaction. This study identifies key regions in Cdk2 essential for p21 binding, aiding in understanding cell cycle regulation.

Area of Science:

  • Molecular Biology
  • Cell Cycle Regulation
  • Protein-Protein Interactions

Background:

  • p21 is a cyclin-dependent kinase (Cdk) inhibitor that regulates cell cycle progression by inducing G1 arrest.
  • Previous research indicated that amino acids 46-78 of p21 are essential for binding to Cdk2 and inhibiting its kinase activity.
  • The specific binding sites on Cdk2 for p21 have not been identified.

Purpose of the Study:

  • To identify the specific region(s) on Cdk2 responsible for binding to the cyclin-dependent kinase (Cdk) inhibitor p21.
  • To investigate the role of different domains of Cdk2 in mediating p21 interaction.
  • To complement existing crystallographic data on Cdk2-p21 interactions.

Main Methods:

  • Construction and testing of various N-terminal and C-terminal deletion mutants of Cdk2 for p21 binding.
  • Utilizing yeast two-hybrid and double-tagging assays to assess protein interactions.
  • Creating and analyzing Cdk2/Cdk7 and Cdk2/Cdc28 hybrid proteins to map p21 binding domains.
  • Mutagenesis of hybrid proteins to identify specific residues involved in p21 binding.

Main Results:

  • Deletion mutants of Cdk2 did not bind to p21, suggesting the importance of intact domains.
  • Hybrid molecules revealed that the amino-terminal half of Cdk2, but not Cdk7, is critical for p21 binding.
  • The yeast protein Cdc28, homologous to Cdk2, also failed to bind p21, but Cdk2/Cdc28 hybrids could bind, further implicating Cdk2's N-terminus.
  • Mutagenesis of hybrid proteins yielded mutants capable of binding p21, pinpointing key residues.

Conclusions:

  • The amino-terminal half of Cdk2 is essential for binding to the Cdk inhibitor p21.
  • Deletion of terminal regions may alter the three-dimensional structure of Cdk2, affecting p21 interaction.
  • This study provides valuable insights into the molecular basis of Cdk2-p21 interaction and offers a method for identifying critical binding residues.

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Positive Regulator Molecules02:39

Positive Regulator Molecules

Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.
M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Anaphase Promoting Complex00:50

Anaphase Promoting Complex

The stepwise destruction of specific proteins is necessary for the progression and completion of the cell cycle. Such proteins are ubiquitinated by ubiquitin ligases and then subsequently destroyed by the proteasome. The SCF (Skp1/Cullin/F-box) and the anaphase-promoting complex (APC) are two important ubiquitin ligases involved in cell cycle progression. While SCF is active throughout the cell cycle, APC gets activated during metaphase to anaphase transition. Cdc20 or Cdh1 binds to APC and...